TailorCare Expands Value-Based MSK Care for Humana Medicare Advantage in Dallas, Denver
TailorCare, a provider specializing in value-based musculoskeletal (MSK) care, is expanding its partnership with Humana to include Medicare Advantage (MA) members in Dallas and Denver. This expansion follows the existing program in Atlanta and aims to offer personalized, evidence-based care coordination and navigation for MSK conditions affecting Humana members. The initiative focuses on proactive management of musculoskeletal health issues such as arthritis and osteoporosis, which significantly impact the U.S. healthcare system with costs exceeding $400 billion annually.
The TailorCare model emphasizes early intervention, engaging patients before their pain escalates to more invasive and costly treatments. Each participating Humana MA member undergoes a structured clinical evaluation by licensed physical therapists, which informs a tailored care plan. These plans may involve conservative therapies, referrals to in-network specialists, in-person physical therapy, and at-home self-care strategies, enhancing the overall quality and efficiency of care.
Through this partnership, Humana members will also access an advanced home-based exercise program for physical therapy, supporting continuous and convenient rehabilitation. This approach represents a broader shift toward patient-centered, value-based care models that aim to improve health outcomes while managing costs. It leverages data-driven insights and evidence-based guidelines to personalize treatment pathways, optimizing the effectiveness of interventions and member satisfaction.
By expanding these services to new markets, TailorCare and Humana are addressing a high-prevalence health concern with comprehensive support that integrates clinical expertise, predictive analytics, and coordinated care. This collaboration aligns with ongoing trends in healthcare emphasizing preventive care and tailored patient experiences within Medicare Advantage plans. Stakeholders should monitor such developments as they may influence payer-provider relationships and the structuring of future MSK care delivery models.